DE602004031079D1 - Neue bifidobacterium-stämme mit der fähigkeit zur herstellung von glutamin - Google Patents
Neue bifidobacterium-stämme mit der fähigkeit zur herstellung von glutaminInfo
- Publication number
- DE602004031079D1 DE602004031079D1 DE602004031079T DE602004031079T DE602004031079D1 DE 602004031079 D1 DE602004031079 D1 DE 602004031079D1 DE 602004031079 T DE602004031079 T DE 602004031079T DE 602004031079 T DE602004031079 T DE 602004031079T DE 602004031079 D1 DE602004031079 D1 DE 602004031079D1
- Authority
- DE
- Germany
- Prior art keywords
- colitis
- strains
- bifidobacterium
- days
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000186000 Bifidobacterium Species 0.000 title abstract 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title abstract 3
- 206010009887 colitis Diseases 0.000 abstract 5
- 229920003045 dextran sodium sulfate Polymers 0.000 abstract 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 abstract 2
- 241000700159 Rattus Species 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- 206010070545 Bacterial translocation Diseases 0.000 abstract 1
- 208000037112 Intestinal Failure Diseases 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 241000186606 Lactobacillus gasseri Species 0.000 abstract 1
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 241000700157 Rattus norvegicus Species 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000007375 bacterial translocation Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000009266 disease activity Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000002443 hepatoprotective effect Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000008383 multiple organ dysfunction Effects 0.000 abstract 1
- 230000008092 positive effect Effects 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000005070 sampling Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000005945 translocation Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0300245A SE526711C2 (sv) | 2003-01-31 | 2003-01-31 | Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav |
| US44727403P | 2003-02-14 | 2003-02-14 | |
| PCT/SE2004/000098 WO2004067731A1 (en) | 2003-01-31 | 2004-01-27 | New strains of bifidobacterium having the ability to produce glutamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004031079D1 true DE602004031079D1 (de) | 2011-03-03 |
Family
ID=20290264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004031079T Expired - Lifetime DE602004031079D1 (de) | 2003-01-31 | 2004-01-27 | Neue bifidobacterium-stämme mit der fähigkeit zur herstellung von glutamin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7947482B2 (enExample) |
| EP (1) | EP1587913B1 (enExample) |
| JP (1) | JP4540664B2 (enExample) |
| CN (1) | CN100558883C (enExample) |
| AT (1) | ATE496115T1 (enExample) |
| AU (1) | AU2004208084B2 (enExample) |
| BR (1) | BRPI0407176B8 (enExample) |
| CA (1) | CA2514659C (enExample) |
| DE (1) | DE602004031079D1 (enExample) |
| DK (1) | DK1587913T3 (enExample) |
| ES (1) | ES2362496T3 (enExample) |
| PL (1) | PL212096B1 (enExample) |
| RU (1) | RU2352628C2 (enExample) |
| SE (1) | SE526711C2 (enExample) |
| WO (1) | WO2004067731A1 (enExample) |
| ZA (1) | ZA200505777B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2561629T3 (es) | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
| DK1951272T3 (en) * | 2005-10-06 | 2016-09-19 | Probi Ab | Use of lactobacillus for treatment of virus infections |
| CN105671120B (zh) * | 2010-07-05 | 2019-02-19 | 株式会社明治 | 具有肠内腐败物质的减少作用的双歧杆菌 |
| CL2010001124A1 (es) | 2010-10-14 | 2011-01-21 | Univ De Concepcion 50% Ma Loreto Ormeno 50% | Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia. |
| KR20130049671A (ko) | 2011-11-04 | 2013-05-14 | 한미사이언스 주식회사 | 생리활성 폴리펩타이드 결합체 제조 방법 |
| CN103131647B (zh) * | 2011-11-29 | 2017-06-27 | 上海上药信谊药厂有限公司 | 婴儿双歧杆菌及其制剂 |
| CN104780932A (zh) | 2012-02-29 | 2015-07-15 | 伊西康内外科公司 | 微生物区系的组合物及与其相关的方法 |
| AR090281A1 (es) | 2012-03-08 | 2014-10-29 | Hanmi Science Co Ltd | Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo |
| EP4529950A3 (en) | 2014-10-31 | 2025-08-20 | Pendulum Therapeutics, Inc. | Methods and compositions relating to microbial treatment |
| WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
| CN108330166A (zh) * | 2017-09-06 | 2018-07-27 | 深圳市百澳飞生物技术有限公司 | 一种酶制剂的饲用活性评估方法 |
| WO2020018949A2 (en) | 2018-07-19 | 2020-01-23 | Pendulum Therapeutics, Inc. | Methods and compositions for microbial engraftment |
| RU2699967C1 (ru) * | 2018-12-25 | 2019-09-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) | Способ комплексного лечения энтеральной недостаточности у детей с тяжелой термической травмой |
| US11045507B2 (en) | 2019-02-21 | 2021-06-29 | Ewelina Sosnowska-Turek | Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59155321A (ja) * | 1983-02-25 | 1984-09-04 | Riyoushiyoku Kenkyukai | 整腸用製剤 |
| DE3406772A1 (de) * | 1984-02-24 | 1986-03-13 | Angelo 8137 Berg Schuler | Diaetetisches mittel zur herabsetzung der harnstoffkonzentration in koerperfluessigkeiten und seine herstellung |
| SE9002732D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product containing growth factor |
| IT1254210B (it) | 1992-02-10 | 1995-09-14 | Simone Claudio De | Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego |
| JP3623977B2 (ja) * | 1993-10-29 | 2005-02-23 | 明治乳業株式会社 | 潰瘍性大腸炎治療剤 |
| JP4852681B2 (ja) * | 1996-02-28 | 2012-01-11 | 雪印メグミルク株式会社 | 腸管内細胞溶解活性抑制剤 |
| IT1288119B1 (it) * | 1996-06-28 | 1998-09-10 | Renata Maria Anna Ve Cavaliere | Composizioni dietetiche da utilizzare nell'alimentazione per via enterica |
| RU2112034C1 (ru) * | 1996-12-26 | 1998-05-27 | Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского | Штамм bifidobacterium infantis 73-15, используемый для приготовления бифидосодержащих бактерийных препаратов и продуктов лечебно-диетического питания |
| CN1099289C (zh) * | 1997-08-01 | 2003-01-22 | 北京东方百信生物技术有限公司 | 改善肠道生态平衡的微生物制剂及其工艺 |
| US6203797B1 (en) * | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
| ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
| AU6160200A (en) * | 1999-08-05 | 2001-03-05 | Societe Des Produits Nestle S.A. | New bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| US6468525B1 (en) * | 1999-08-10 | 2002-10-22 | Renew Life, Inc. | Probiotic formulation |
| CA2407724A1 (en) | 2000-05-03 | 2001-11-08 | University Of Maryland, Baltimore | Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal |
| AU2001265253A1 (en) * | 2000-07-07 | 2002-01-21 | First Circle Medical, Inc. | Treatment of hiv using hyperthermia |
| JP2002186422A (ja) * | 2000-12-22 | 2002-07-02 | Morinaga Milk Ind Co Ltd | ラクトバシラス・ガッセリ及びビフィドバクテリウム属の菌を含有する非発酵食品 |
| FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
| ATE375164T1 (de) * | 2001-02-06 | 2007-10-15 | Nestle Sa | Endotoxin-bindung durch milchsäurebakterien und bifidobacteria |
| US20030017192A1 (en) * | 2001-06-19 | 2003-01-23 | Hanny Kanafani | Process for producing extended shelf-life ready-to-use milk compositions containing probiotics |
| PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
| JP3364491B2 (ja) * | 2002-07-25 | 2003-01-08 | 株式会社アトリエ・ド・フロマージュ | ヨーグルトおよびその製造方法 |
-
2003
- 2003-01-31 SE SE0300245A patent/SE526711C2/sv not_active IP Right Cessation
-
2004
- 2004-01-27 DK DK04705562.9T patent/DK1587913T3/da active
- 2004-01-27 AT AT04705562T patent/ATE496115T1/de not_active IP Right Cessation
- 2004-01-27 PL PL378435A patent/PL212096B1/pl unknown
- 2004-01-27 ZA ZA200505777A patent/ZA200505777B/en unknown
- 2004-01-27 ES ES04705562T patent/ES2362496T3/es not_active Expired - Lifetime
- 2004-01-27 US US10/543,604 patent/US7947482B2/en active Active
- 2004-01-27 AU AU2004208084A patent/AU2004208084B2/en not_active Expired
- 2004-01-27 RU RU2005127331/13A patent/RU2352628C2/ru active
- 2004-01-27 BR BRPI0407176A patent/BRPI0407176B8/pt not_active IP Right Cessation
- 2004-01-27 JP JP2006502776A patent/JP4540664B2/ja not_active Expired - Lifetime
- 2004-01-27 EP EP04705562A patent/EP1587913B1/en not_active Expired - Lifetime
- 2004-01-27 DE DE602004031079T patent/DE602004031079D1/de not_active Expired - Lifetime
- 2004-01-27 WO PCT/SE2004/000098 patent/WO2004067731A1/en not_active Ceased
- 2004-01-27 CN CNB2004800088252A patent/CN100558883C/zh not_active Expired - Lifetime
- 2004-01-27 CA CA2514659A patent/CA2514659C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20060269533A1 (en) | 2006-11-30 |
| WO2004067731A1 (en) | 2004-08-12 |
| CN1777670A (zh) | 2006-05-24 |
| SE0300245L (sv) | 2004-08-01 |
| SE0300245D0 (sv) | 2003-01-31 |
| CA2514659C (en) | 2014-07-08 |
| EP1587913A1 (en) | 2005-10-26 |
| US7947482B2 (en) | 2011-05-24 |
| PL212096B1 (pl) | 2012-08-31 |
| PL378435A1 (pl) | 2006-04-03 |
| JP4540664B2 (ja) | 2010-09-08 |
| AU2004208084B2 (en) | 2008-10-09 |
| ES2362496T3 (es) | 2011-07-06 |
| SE526711C2 (sv) | 2005-10-25 |
| EP1587913B1 (en) | 2011-01-19 |
| CA2514659A1 (en) | 2004-08-12 |
| DK1587913T3 (da) | 2011-04-11 |
| JP2006516405A (ja) | 2006-07-06 |
| ATE496115T1 (de) | 2011-02-15 |
| RU2005127331A (ru) | 2006-01-27 |
| BRPI0407176A (pt) | 2006-02-07 |
| ZA200505777B (en) | 2007-12-27 |
| AU2004208084A1 (en) | 2004-08-12 |
| RU2352628C2 (ru) | 2009-04-20 |
| CN100558883C (zh) | 2009-11-11 |
| BRPI0407176B8 (pt) | 2021-05-25 |
| BRPI0407176B1 (pt) | 2018-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE496115T1 (de) | Neue bifidobacterium-stämme mit der fähigkeit zur herstellung von glutamin | |
| RU2465320C2 (ru) | Композиция штаммов рода lactobacillus для производства лекарственного средства | |
| CN108836956B (zh) | 甘草查耳酮a在制备治疗鸡坏死性肠炎药物中的用途 | |
| JPH07126177A (ja) | 潰瘍性大腸炎治療剤 | |
| CN1300617A (zh) | 一种补正气、泻邪气、调整人体阳气升降出入的中药组合物 | |
| Şahin et al. | The impact of oral feeding on the severity of acute pancreatitis | |
| CA3232874A1 (en) | Hygromycin a for treatment of diseases and infections | |
| CN108309969B (zh) | 鸢尾黄素在治疗鸡坏死性肠炎中的医用用途 | |
| Verdecia et al. | Trivalvular infective endocarditis secondary to Granulicatella adiacens and Peptostreptococcus spp | |
| CN118384186A (zh) | Akkermansia muciniphila及其后生元在抗感染中的应用 | |
| Harboe | Armauer Hansen-the man and his work | |
| CN105343132B (zh) | 治疗结肠炎的组合物、药物及其制备方法 | |
| MAKSUDOV et al. | Development of a comprehensive programme for the comprehensive treatment of patients with maxillofacial phlegmon with viral hepatitis B | |
| Ozcelik et al. | The role of lactulose in the prevention of bacterial translocation in surgical trauma | |
| GB1585863A (en) | Pharmaceutical lactobacillus preparations | |
| Marshall Jr et al. | The variable effects of sulfonamides on fecal bacteria in patients with chronic ulcerative colitis: a preliminary report | |
| Wang et al. | Moxibustion at Front-Mu point of abdomen for intestinal dysbacteriosis in rats | |
| Finley | Dermato-Myositis | |
| SU1588414A1 (ru) | Способ лечени ожоговой болезни | |
| Crisostomo et al. | A randomized double blind controlled study on the efficacy of spirulina as an adjunct therapy in the management of pediatric community acquired pneumonia-c in patients 6 months to 5 years old admitted in a tertiary government hospital | |
| CN120249099A (zh) | 一株罗伊氏粘液乳杆菌ccfm1453制备的促进胃黏膜修复的多糖 | |
| CN120168459A (zh) | 独活素在制备治疗和/或缓解新生儿感染性疾病及脏器损伤的药物中的应用 | |
| RU2008110773A (ru) | Способ лечения онкологических заболеваний | |
| Malsbary | Rheumatism | |
| Sharma et al. | Therapeutic and dietary management of colibacillosis in calves |